title: [Practical guidelines for diagnosis and treatment of acromegaly. Grupo de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición].
authors: Servicio de Endocrinología y Nutrición, Hospital Universitario A Coruña, A Coruña, España.
authors: Fernando
authors: F
authors: Cordido
authors: Juan Antonio
authors: JA
authors: García Arnés
authors: Mónica
authors: M
authors: Marazuela Aspiroz
authors: Elena
authors: E
authors: Torres Vela
mesh_terms: D000172:Acromegaly / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D000236:Adenoma / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism / Q000532:radiotherapy / Q000601:surgery; D000465:Algorithms; D003131:Combined Modality Therapy; D015897:Comorbidity; D016371:Cranial Irradiation / Q000379:methods; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005951:Glucose Tolerance Test; D049912:Growth Hormone-Secreting Pituitary Adenoma / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism / Q000532:radiotherapy / Q000601:surgery; D019382:Human Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000097:blood / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D007016:Hypophysectomy / Q000379:methods; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008279:Magnetic Resonance Imaging; D020360:Neoadjuvant Therapy; D019990:Perioperative Care; D010641:Phenotype; D010911:Pituitary Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000378:metabolism / Q000532:radiotherapy / Q000601:surgery; D013004:Somatostatin / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives / Q000627:therapeutic use; D063189:Symptom Assessment
chemical_list: D018491:Dopamine Agonists; D019382:Human Growth Hormone; D013004:Somatostatin; D007334:Insulin-Like Growth Factor I; C406545:pegvisomant
keywords: Acromegalia; Adenoma hipofisario; Agonistas dopaminérgicos; Antagonista del receptor de la hormona del crecimiento; Análogos de somatostatina; Factor de crecimiento insulínico tipo 1; Hormona del crecimiento